Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin’s Lymphoma
Lymphoma
-
-
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin’s Lymphoma
-
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
-
Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
-
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt’s Lymphoma or Burkitt’s Leukemia
-
Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
-
Rituximab in Treating Patients With Non-Hodgkin’s Lymphoma or Hodgkin’s Disease
-
Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin’s Lymphoma
Categories
Alliance Committee
Browse by Year